Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuto Yagi

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Urology|June 7, 2015
Schmorl Nodes Mimicking Osteolytic Bone MetastasesNaoya Niwa, Toru Nishiyama, Choichiro Ozu, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|December 24, 2011
[PSA bounce after brachytherapy with permanent seed implantation for prostate cancer]Yasuto Yagi, Ryo Namitome, Yuho Kono, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|November 6, 2012
[Sexual function after permanent seed implant prostate brachytherapy]Yasuto Yagi, Ryo Namitome, Yuho Kono, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 25, 2013
[Two cases of bowel perforation in patients with metastatic renal cancer treated with a molecularly targeted drug]Hiroaki Kobayashi, Asuka Ashikari, Ryo Namitome, et al.
Brachytherapy|October 18, 2020
Effect of adding androgen deprivation therapy to permanent iodine-125 implantation with or without external beam radiation therapy on the outcomes in patients with intermediate-risk prostate cancer: A propensity score-matched analysisShinya Sutani, Atsunori Yorozu, Kazuhito Toya, et al.
Brachytherapy|September 25, 2018
Selection of patients who would not require long-term prostate-specific antigen monitoring after low-dose-rate brachytherapyNaoya Niwa, Kazuhiro Matsumoto, Toru Nishiyama, et al.
Brachytherapy|April 24, 2022
Secondary bladder cancer during long-term follow-up after iodine-125 permanent seed implantation for localized prostate cancerYu Ozawa, Yasuto Yagi, Ken Nakamura, et al.
Journal of Contemporary Brachytherapy|August 23, 2019
Whole-gland salvage treatment for recurrent prostate cancer after initial definitive radiotherapy: A case series of <sup>125</sup>I brachytherapy and robot-assisted radical prostatectomyShinya Sutani, Atsunori Yorozu, Kazuhito Toya, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2014
A dose-response analysis of biochemical control outcomes after (125)I monotherapy for patients with favorable-risk prostate cancerYutaka Shiraishi, Atsunori Yorozu, Toshio Ohashi, et al.
The Prostate|January 4, 2024
Fewer systematic prostate core biopsies in clinical stage T1c prostate cancer leads to biochemical recurrence after brachytherapy as monotherapyYu Ozawa, Sunao Nohara, Ken Nakamura, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Urology|June 7, 2015
Schmorl Nodes Mimicking Osteolytic Bone MetastasesNaoya Niwa, Toru Nishiyama, Choichiro Ozu, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|December 24, 2011
[PSA bounce after brachytherapy with permanent seed implantation for prostate cancer]Yasuto Yagi, Ryo Namitome, Yuho Kono, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|November 6, 2012
[Sexual function after permanent seed implant prostate brachytherapy]Yasuto Yagi, Ryo Namitome, Yuho Kono, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 25, 2013
[Two cases of bowel perforation in patients with metastatic renal cancer treated with a molecularly targeted drug]Hiroaki Kobayashi, Asuka Ashikari, Ryo Namitome, et al.
Brachytherapy|October 18, 2020
Effect of adding androgen deprivation therapy to permanent iodine-125 implantation with or without external beam radiation therapy on the outcomes in patients with intermediate-risk prostate cancer: A propensity score-matched analysisShinya Sutani, Atsunori Yorozu, Kazuhito Toya, et al.
Brachytherapy|September 25, 2018
Selection of patients who would not require long-term prostate-specific antigen monitoring after low-dose-rate brachytherapyNaoya Niwa, Kazuhiro Matsumoto, Toru Nishiyama, et al.
Brachytherapy|April 24, 2022
Secondary bladder cancer during long-term follow-up after iodine-125 permanent seed implantation for localized prostate cancerYu Ozawa, Yasuto Yagi, Ken Nakamura, et al.
Journal of Contemporary Brachytherapy|August 23, 2019
Whole-gland salvage treatment for recurrent prostate cancer after initial definitive radiotherapy: A case series of <sup>125</sup>I brachytherapy and robot-assisted radical prostatectomyShinya Sutani, Atsunori Yorozu, Kazuhito Toya, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2014
A dose-response analysis of biochemical control outcomes after (125)I monotherapy for patients with favorable-risk prostate cancerYutaka Shiraishi, Atsunori Yorozu, Toshio Ohashi, et al.
The Prostate|January 4, 2024
Fewer systematic prostate core biopsies in clinical stage T1c prostate cancer leads to biochemical recurrence after brachytherapy as monotherapyYu Ozawa, Sunao Nohara, Ken Nakamura, et al.
Pageof 2